2018 Lead Sponsor

Tata Consultancy Services

2018 Associate Sponsors

Actigraph
Medable

2018 Exhibitors

Activinsights
Illingworth Research Group
McRoberts

2018 Media Partners

Karger
pharmaphorum
SciDoc Publishers
The Journal of mHealth
Technology Networks

Event Blog


  • May 18, 2018

  • DPharm Podcast Series: Blockchain to Speed up Drug Development

    We are happy to share one of the best rated sessions at DPharm 2017 on blockchain’s role in drug development. Presented by Sascha Mundstein, Mobile and Digital COE, Technology Evangelist, Pfizer, Inc. he addresses how blockchain can potentially change the business model of clinical development. Pfizer’s pioneering of a prototype application on the chain has […]

    We are happy to share one of the best rated sessions at DPharm 2017 on blockchain’s role in drug development. Presented by Sascha Mundstein, Mobile and Digital COE, Technology Evangelist, Pfizer, Inc. he addresses how blockchain can potentially change the business model of clinical development. Pfizer’s pioneering of a prototype application on the chain has made them one of the leading companies in blockchain technology. Listen to this podcast to Sascha’s discussion on:

    • The basics on how blockchain works and what the key advantages are
    • Key benefits to empowering patients with control over their data
    • The compliance implications of unalterable historic audit trails
    • How in-house proof of concept development fosters innovation and new technology adoption
    • The implications of rich and abundant patient data

    DPharm 2018 will be featuring a member of the Estonian government on how most of the country has gone digital and with the use of blockchain keeps data private, secure and with the patient. Join us at the next DPharm conference, September 25-26 in Boston, to hear more about this and other ways disruptive innovations can advance clinical trials. Register now to take advantage of pre-early bird prices. Never stop innovating!

    Read More

  • May 9, 2018

  • GDPR Impact on Medical Apps session confirmed for this Week’s London Meeting

    Analogical, digital, device and sensor data linked to a living natural person is in scope of the EU’s new privacy framework, the GDPR. When such data is also biometric, genetic or carries information about someone’s health, it attracts an even higher protection. Medical and scientific research benefits from certain exemptions, but knowing which ones apply […]

    Chiara Rustici

    Chiara Rustici

    Analogical, digital, device and sensor data linked to a living natural person is in scope of the EU’s new privacy framework, the GDPR. When such data is also biometric, genetic or carries information about someone’s health, it attracts an even higher protection. Medical and scientific research benefits from certain exemptions, but knowing which ones apply and how to design and use medical apps and connected devices lawfully is absolutely non-negotiable for the clinical deployment of digital biomarkers and innovation digital health-care.

    Get the latest updates from GDPR analyst, Chiara Rustici at Mobile in Clinical Trials Europe, May 15-16, 2018 in London.  For more information visit: www.theconferenceforum.org/conferences/mobile-clinical-trials-europe/overview.

    Read More

  • May 1, 2018

  • Leveraging Digital Within a Robust Framework to Transform Clinical Trials – Free Whitepaper

    Digital Clinical Trials: The Digital Reimagination™ of Clinical Trials To reduce delays caused by patient recruitment and dropout rates during clinical trials, enterprises need to conduct a ‘digital’ trial within a robust framework. This can help: – Build trust to proactively engage patients – Optimize trial design & productivity – Enhance study monitoring to predict […]

    Digital Clinical Trials: The Digital Reimagination™ of Clinical Trials

    To reduce delays caused by patient recruitment and dropout rates during clinical trials, enterprises need to conduct a ‘digital’ trial within a robust framework.

    This can help:

    • – Build trust to proactively engage patients
    • – Optimize trial design & productivity
    • – Enhance study monitoring to predict results

    Access this free whitepaper presented by TATA Consultancy Services, Lead Sponsor of the Mobile in Clinical Trials Europe program taking place May 15-16, 2018 in London. The program will cover the most relevant and helpful content and case studies on what it takes to launch, execute and scale mobile tools in medicines development.

    Learn more about Mobile in Clinical Trials Europe.

    #MobileEU2018

    Read More